San Diego, Calif.-based NuVasive has received 510(k) clearance from the FDA for its Pulse platform, which is used in spinal surgery.

The platform combines several technologies, including imaging enhancement, navigation technology, neuromonitoring, global alignment, patient-specific rod bending and wireless connectivity.

NuVasive received the CE mark for the platform earlier this summer.